Chemical activators of ZNF708 can regulate its activity through various biochemical pathways, primarily involving kinase signaling cascades. Bisindolylmaleimide I, for instance, selectively inhibits protein kinase C (PKC), which could result in a compensatory activation of protein kinase A (PKA). PKA is known for its ability to phosphorylate specific substrates that can activate ZNF708 through phosphorylation-dependent mechanisms. Similarly, PDBu directly activates PKC, which might also phosphorylate substrates within the ZNF708 signaling pathways, thereby promoting its activation. Another potent activator, Forskolin, stimulates adenylyl cyclase, increasing cyclic AMP (cAMP) levels and thus activating PKA, which, in turn, can lead to ZNF708 activation. Additionally, Ionomycin can elevate intracellular calcium levels and subsequently activate calcium/calmodulin-dependent protein kinases (CaMKs), which can phosphorylate and activate ZNF708.
Furthermore, Okadaic Acid and Calyculin A inhibit protein phosphatases 1 and 2A, leading to sustained phosphorylation within the ZNF708 pathway. Anisomycin activates stress-activated protein kinases (SAPKs), which can also lead to the phosphorylation of ZNF708. Epigallocatechin Gallate, by inhibiting phosphodiesterases, raises cAMP levels that activate PKA, which then can activate ZNF708. Dibutyryl-cAMP, being a cAMP analog, directly activates PKA, which can phosphorylate and activate ZNF708. Thapsigargin disrupts calcium homeostasis and leads to the activation of calcium-dependent kinases, which could phosphorylate ZNF708. Staurosporine, at low concentrations, can non-selectively activate kinases potentially leading to ZNF708 activation. Lastly, Phosphatidic Acid activates mTOR signaling pathways, which are known to lead to phosphorylation and functional activation of ZNF708. Each of these chemicals, by targeting specific kinases or phosphatases, facilitates the phosphorylation state that promotes ZNF708 activation, illustrating the interconnected nature of cellular signaling pathways and the complex regulation of protein function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I selectively inhibits protein kinase C (PKC), which can lead to compensatory activation of protein kinase A (PKA). PKA is known to phosphorylate specific substrates that can activate ZNF708 through phosphorylation-dependent mechanisms. | ||||||
(+)-cis,trans-Abscisic acid | 21293-29-8 | sc-202103 sc-202103A | 500 µg 1 mg | $107.00 $192.00 | ||
Phorbol 12,13-dibutyrate (PDBu) directly activates PKC. Activated PKC can phosphorylate proteins that are involved in the same signaling pathways as ZNF708, leading to its functional activation. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin increases intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases (CaMKs). These kinases can phosphorylate and activate proteins in the same pathway as ZNF708. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases 1 and 2A, which prevents dephosphorylation of proteins, potentially keeping ZNF708 in an activated phosphorylated state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to Okadaic Acid, Calyculin A inhibits protein phosphatases, leading to sustained phosphorylation and activation of proteins within ZNF708's pathway. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), which can phosphorylate and activate proteins within the same signaling networks as ZNF708. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate inhibits phosphodiesterases, leading to increased cAMP levels that activate PKA, which may activate ZNF708 through phosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA directly, potentially leading to the activation of ZNF708 through phosphorylation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting SERCA, leading to activation of calcium-dependent kinases that could phosphorylate and activate ZNF708. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
At low concentrations, Staurosporine can activate certain kinases, which could lead to the phosphorylation and activation of ZNF708. | ||||||